Project Details
Description
A Phase III Study of 131I Metaiodobenzylguanidine (131I-MIBG) or Crizotinib Added t Intensive Therapy for Children With Newly Diagnosed High-Risk Neuroblastoma (NBL)
Status | Finished |
---|---|
Effective start/end date | 1/1/19 → 12/31/21 |
Funding
- THE CHILDREN'S HOSPITAL OF PHILADELPHIA
- JUBILANT DRAXLMAGE INC
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.